SERUM FREE PROSTATE SPECIFIC ANTIGEN AND PROSTATE SPECIFIC ANTIGEN DENSITY MEASUREMENTS FOR PREDICTING CANCER IN MEN WITH PRIOR NEGATIVE PROSTATIC BIOPSIES-Reference-Cited by-同舟云学术

SERUM FREE PROSTATE SPECIFIC ANTIGEN AND PROSTATE SPECIFIC ANTIGEN DENSITY MEASUREMENTS FOR PREDICTING CANCER IN MEN WITH PRIOR NEGATIVE PROSTATIC BIOPSIES

Published:1997-12 Issue:6 Volume:158 Page:2162-2167
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Catalona William J.,Beiser Julia A.,Smith Deborah S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference13 articles.

1. Serial prostate biopsies in men with persistently elevated serum prostate specific antigen values.;Keetch;J. Urol.,1994

2. Serum concentration of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer;Stenman;Lancet,1994

3. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen.;Luderer;Urology,1995

4. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.;Catalona;J.A.M.A.,1995

5. An algorithm for prostate cancer detection based upon PSA, TRUS, DRE, PSA density and PSA velocity;Seaman;J. Urol.,1993

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer;Journal of Modern Oncology;2021-08-16

2. Predictive factors of prostate cancer diagnosis with PSA 4.0–10.0 ng/ml in a multi-ethnic Asian population, Malaysia;Asian Journal of Surgery;2020-01

3. Clinical Aspects and Investigations in Genitourinary Cancer;Urologic Oncology;2019

4. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ng/mL;International braz j urol;2018-08

5. Clinical Aspects and Investigations in Genitourinary Cancer;Urologic Oncology;2018